Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,979,029 papers from all fields of science
Search
Sign In
Create Free Account
ovarian sarcoma
Known as:
Sarcoma of Ovary
, sarcoma, ovarian
, ovarian sarcomas
Expand
A rare, aggressive malignant mesenchymal neoplasm that arises from the ovary. The prognosis is poor.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
Connective and Soft Tissue
Epithelial Cells
Epithelium
Female Reproductive System
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Primary synovial sarcoma of the ovary: first reported case
Christopher J. Smith
,
A. Ferrier
,
P. Russell
,
S. Danieletto
Pathology (Sydney)
2005
Corpus ID: 31842443
Review
2003
Review
2003
Theanine and glutamate transporter inhibitors enhance the antitumor efficacy of chemotherapeutic agents.
T. Sugiyama
,
Y. Sadzuka
Biochimica et Biophysica Acta
2003
Corpus ID: 21918690
Highly Cited
2001
Highly Cited
2001
Inhibition of glutamate transporter by theanine enhances the therapeutic efficacy of doxorubicin.
T. Sugiyama
,
Y. Sadzuka
,
Koichi Tanaka
,
T. Sonobe
Toxicology Letters
2001
Corpus ID: 24778677
Highly Cited
1999
Highly Cited
1999
Combination of theanine with doxorubicin inhibits hepatic metastasis of M5076 ovarian sarcoma.
T. Sugiyama
,
Y. Sadzuka
Clinical Cancer Research
1999
Corpus ID: 17998855
Theanine is a peculiar amino acid existing in green tea leaves, which was previously indicated to enhance the antitumor activity…
Expand
Review
1997
Review
1997
Malignant mixed mesodermal ovarian tumor treatment and prognosis: a 20-year experience.
T. Le
,
G. Krepart
,
R. Lotocki
,
M. Heywood
Gynecologic Oncology
1997
Corpus ID: 1488268
Mixed mesodermal sarcoma of the ovary is a rare clinical entity. To review the epidemiology, prognostic factors, and treatment…
Expand
1994
1994
Effects of E-64 (cysteine-proteinase inhibitor) and pepstatin (aspartyl-proteinase inhibitor) on metastasis formation in mice with mammary and ovarian tumors.
G. Leto
,
G. Pizzolanti
,
F. Tumminello
,
N. Gebbia
In Vivo
1994
Corpus ID: 29949793
The effects of E-64 (Cathepsin B and L inhibitor) and Pepstatin A (Cathepsin D inhibitor) on spontaneous and experimental…
Expand
1993
1993
Granulocytic sarcoma of the ovary in a nonleukemic patient.
R. C. Aguiar
,
D. Pozzi
,
D. Chamone
Haematologica
1993
Corpus ID: 28566450
We report a case of granulocytic sarcoma of the ovary preceding acute myeloid leukemia by twelve months, with no evidence of any…
Expand
1988
1988
The clinical significance of pre‐operative serum CA 125 in ovarian cancer
D. Cruickshank
,
W. Fullerton
,
A. Klopper
1988
Corpus ID: 30824961
Highly Cited
1987
Highly Cited
1987
The clinical significance of pre‐operative serum CA 125 in ovarian cancer
D. Cruickshank
,
W. Fullerton
,
A. Klopper
British Journal of Obstetrics and Gynaecology
1987
Corpus ID: 70620562
In a prospective study of 52 patients with ovarian malignancy followed up for 3–18 months the clinical significance of pre…
Expand
1952
1952
Osteogenic sarcoma of the ovary.
L. Stowe
,
J. Watt
American Journal of Obstetrics and Gynecology
1952
Corpus ID: 993032
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE